These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 12048682

  • 1. [Effects of wild-type p53 gene on the chemotherapy sensitivity of ovarian cancer SKOV-3 cells to cisplatin].
    Jin Z, Guan T, Li S.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):218-20. PubMed ID: 12048682
    [Abstract] [Full Text] [Related]

  • 2. [Biologic effects of introduction of wild-type p53 cDNA into a human ovarian cancer cell line SKOV-3].
    You Z, Guo Y, Cao Z.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Dec; 32(12):715-7. PubMed ID: 9772432
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.
    Coukos G, Makrigiannakis A, Kang EH, Rubin SC, Albelda SM, Molnar-Kimber KL.
    Clin Cancer Res; 2000 Aug; 6(8):3342-53. PubMed ID: 10955822
    [Abstract] [Full Text] [Related]

  • 7. Differential effects of novel tumour-derived p53 mutations on the transformation of NIH-3T3 cells.
    Donninger H, Binder A, Bohm L, Parker MI.
    Biol Chem; 2008 Jan; 389(1):57-67. PubMed ID: 18095870
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Suppression of insulin-like growth factor-1 receptor by RNA interference inhibits cell growth in vitro and induces chemosensitization of HO8910PM cell to cisplatin].
    Gao H, Shi J, Ge SF, DI W.
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):45-9. PubMed ID: 18366933
    [Abstract] [Full Text] [Related]

  • 12. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
    Kozubík A, Horváth V, Svihálková-Sindlerová L, Soucek K, Hofmanová J, Sova P, Kroutil A, Zák F, Mistr A, Turánek J.
    Biochem Pharmacol; 2005 Feb 01; 69(3):373-83. PubMed ID: 15652229
    [Abstract] [Full Text] [Related]

  • 13. The p53-regulated cyclin G gene promotes cell growth: p53 downstream effectors cyclin G and Gadd45 exert different effects on cisplatin chemosensitivity.
    Smith ML, Kontny HU, Bortnick R, Fornace AJ.
    Exp Cell Res; 1997 Jan 10; 230(1):61-8. PubMed ID: 9013707
    [Abstract] [Full Text] [Related]

  • 14. Sensitization and caffeine potentiation of cisplatin cytotoxicity resulting from introduction of wild-type p53 gene in human osteosarcoma.
    Tsuchiya H, Mori Y, Ueda Y, Okada G, Tomita K.
    Anticancer Res; 2000 Jan 10; 20(1A):235-42. PubMed ID: 10769661
    [Abstract] [Full Text] [Related]

  • 15. Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells.
    Benassi MS, Chiechi A, Ponticelli F, Pazzaglia L, Gamberi G, Zanella L, Manara MC, Perego P, Ferrari S, Picci P.
    Cancer Lett; 2007 Jun 08; 250(2):194-205. PubMed ID: 17113707
    [Abstract] [Full Text] [Related]

  • 16. Independent pathways of p53 induction by cisplatin and X-rays in a cisplatin-resistant ovarian tumor cell line.
    Siddik ZH, Mims B, Lozano G, Thai G.
    Cancer Res; 1998 Feb 15; 58(4):698-703. PubMed ID: 9485023
    [Abstract] [Full Text] [Related]

  • 17. [Proliferation inhibition and apoptosis onset in human ovarian carcinoma cell line SKOV3 induced by Genistein].
    Li Y, Mi C.
    Ai Zheng; 2003 Jun 15; 22(6):586-91. PubMed ID: 12948406
    [Abstract] [Full Text] [Related]

  • 18. Apoptosis and growth arrest induced by platinum compounds in U2-OS cells reflect a specific DNA damage recognition associated with a different p53-mediated response.
    Gatti L, Supino R, Perego P, Pavesi R, Caserini C, Carenini N, Righetti SC, Zuco V, Zunino F.
    Cell Death Differ; 2002 Dec 15; 9(12):1352-9. PubMed ID: 12478472
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy compounds in cervical cancer cells primed by reconstitution of p53 function after short interfering RNA-mediated degradation of human papillomavirus 18 E6 mRNA: opposite effect of siRNA in combination with different drugs.
    Koivusalo R, Krausz E, Helenius H, Hietanen S.
    Mol Pharmacol; 2005 Aug 15; 68(2):372-82. PubMed ID: 15908516
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.